Akebia Therapeutics, Inc.
AKBA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517022
No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Akebia Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 158
- +15 vs. Q1 2025
- Shares held
- 108.3M
- +12.8M (+13.4%) vs. Q1 2025
- Total value
- $394.1M
- +$211.4M (+115.7%) vs. Q1 2025
- New holders
- 33
- 78 more added
- Sold out
- 18
- 22 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKBA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 170 | $123.2M |
| Q1 2026 | 171 | $141.4M |
| Q4 2025 | 166 | $190.4M |
| Q3 2025 | 177 | $337.7M |
| Q2 2025 | 158 | $394.1M |
| Q1 2025 | 143 | $182.7M |
| Q4 2024 | 121 | $128.9M |
| Q3 2024 | 114 | $78.4M |
| Q2 2024 | 103 | $57.4M |
| Q1 2024 | 114 | $104.3M |
| Q4 2023 | 87 | $72.7M |
| Q3 2023 | 76 | $58.0M |
| Q2 2023 | 79 | $46.0M |
| Q1 2023 | 65 | $29.1M |
| Q4 2022 | 75 | $30.2M |
| Q3 2022 | 90 | $16.5M |
| Q2 2022 | 97 | $20.2M |
| Q1 2022 | 124 | $58.3M |
| Q4 2021 | 133 | $218.7M |
| Q3 2021 | 127 | $283.7M |
| Q2 2021 | 139 | $402.4M |
| Q1 2021 | 145 | $340.3M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Akebia Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mirae Asset Global ETFs Holdings Ltd. | 149,392 | $543.9K | 0.00% | +11,495+8.3% | Added |
| MetLife Investment Management | 149,808 | $545.3K | 0.00% | +31,644+26.8% | Added |
| XTX Topco Ltd | 150,901 | $549.3K | 0.02% | +104,890+228.0% | Added |
| Wells Fargo & Company | 159,591 | $580.9K | 0.00% | +29,469+22.6% | Added |
| Squarepoint Ops LLC | 161,192 | $586.7K | 0.00% | +116,149+257.9% | Added |
| Cubist Systematic Strategies, LLC | 168,738 | $614.2K | 0.01% | +160,903+2,053.6% | Added |
| Ameriprise Financial Inc | 176,948 | $644.1K | 0.00% | +164,896+1,368.2% | Added |
| Price T Rowe Associates Inc | 183,264 | $668.0K | 0.00% | +29,894+19.5% | Added |
| SEI Investments Co | 191,245 | $696.1K | 0.00% | +16,200+9.3% | Added |
| Longaeva Partners L.P. | 191,691 | $697.8K | 0.17% | −308,309−61.7% | Reduced |
| Simplex Trading, LLC | 193,034 | $702.0K | 0.02% | +54,564+39.4% | Added |
| Sapient Capital LLC | 200,000 | $728.0K | 0.01% | 00.0% | Unchanged |
| Panagora Asset Management Inc | 210,205 | $765.1K | 0.00% | +210,205 | New |
| Walleye Capital LLC | 214,817 | $781.9K | 0.01% | +214,817 | New |
| D. E. Shaw & Co., Inc. | 219,089 | $797.5K | 0.00% | +145,928+199.5% | Added |
| Alliancebernstein L.P. | 238,930 | $869.7K | 0.00% | +186,660+357.1% | Added |
| Mackenzie Financial Corp | 248,602 | $904.9K | 0.00% | +11,044+4.6% | Added |
| Rafferty Asset Management, LLC | 253,954 | $924.4K | 0.00% | +47,324+22.9% | Added |
| Creative Planning | 283,330 | $1.03M | 0.00% | +53,660+23.4% | Added |
| ExodusPoint Capital Management, LP | 289,528 | $1.05M | 0.01% | +289,528 | New |
| Rhumbline Advisers | 365,035 | $1.33M | 0.00% | +82,969+29.4% | Added |
| Invesco Ltd. | 382,210 | $1.39M | 0.00% | +121,607+46.7% | Added |
| Prudential Financial Inc | 415,143 | $1.51M | 0.00% | +350,504+542.2% | Added |
| AQR Capital Management LLC | 425,949 | $1.55M | 0.00% | +248,988+140.7% | Added |
| BNP Paribas Arbitrage, SA | 520,629 | $1.90M | 0.00% | +472,855+989.8% | Added |
| Bank of New York Mellon Corp | 615,601 | $2.24M | 0.00% | +122,008+24.7% | Added |
| Federated Hermes, Inc. | 617,318 | $2.25M | 0.00% | −296,131−32.4% | Reduced |
| UBS Group AG | 639,462 | $2.33M | 0.00% | +47,052+7.9% | Added |
| Wellington Management Group LLP | 695,728 | $2.53M | 0.00% | +29,161+4.4% | Added |
| Charles Schwab Investment Management Inc | 749,015 | $2.73M | 0.00% | +126,101+20.2% | Added |
| Susquehanna International Group, LLP | 791,352 | $2.88M | 0.00% | +104,073+15.1% | Added |
| FMR LLC | 813,982 | $2.96M | 0.00% | −58,502−6.7% | Reduced |
| Dimensional Fund Advisors LP | 882,101 | $3.21M | 0.00% | +346,670+64.7% | Added |
| Barclays PLC | 984,512 | $3.58M | 0.00% | +676,377+219.5% | Added |
| Woodline Partners LP | 1,001,360 | $3.64M | 0.02% | −1,484,218−59.7% | Reduced |
| Bank of America Corp | 1,110,480 | $4.04M | 0.00% | +628,570+130.4% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 1,180,759 | $4.30M | 0.02% | +210,925+21.7% | Added |
| Jacobs Levy Equity Management, Inc | 1,205,128 | $4.39M | 0.02% | −374,227−23.7% | Reduced |
| Acadian Asset Management LLC | 1,350,185 | $4.91M | 0.01% | +1,350,185 | New |
| EAM Investors, LLC | 1,454,328 | $5.29M | 0.80% | −323,583−18.2% | Reduced |
| JPMorgan Chase & Co | 1,652,746 | $6.02M | 0.00% | +911,585+123.0% | Added |
| Qube Research & Technologies Ltd | 1,714,544 | $6.24M | 0.01% | +646,267+60.5% | Added |
| Affinity Asset Advisors, LLC | 1,950,000 | $7.10M | 1.05% | +450,000+30.0% | Added |
| Great Point Partners LLC | 1,985,915 | $7.23M | 4.70% | −2,987,925−60.1% | Reduced |
| Nantahala Capital Management, LLC | 2,000,000 | $7.28M | 0.52% | 00.0% | Unchanged |
| Northern Trust Corp | 2,135,244 | $7.77M | 0.00% | +424,053+24.8% | Added |
| Millennium Management LLC | 2,163,499 | $7.88M | 0.01% | +959,647+79.7% | Added |
| Citadel Advisors LLC | 2,317,290 | $8.43M | 0.01% | −1,329,619−36.5% | Reduced |
| Franklin Resources Inc | 2,667,412 | $9.71M | 0.00% | +850.0% | Added |
| Nuveen, LLC | 2,708,676 | $9.86M | 0.00% | +2,358,263+673.0% | Added |
| MPM Oncology Impact Management LP | 2,889,125 | $10.5M | 1.82% | +2,889,125 | New |
| Goldman Sachs Group Inc | 3,934,002 | $14.3M | 0.00% | +1,209,563+44.4% | Added |
| Renaissance Technologies LLC | 4,194,427 | $15.3M | 0.02% | +188,600+4.7% | Added |
| Morgan Stanley | 5,339,654 | $19.4M | 0.00% | +2,658,456+99.2% | Added |
| Geode Capital Management, LLC | 6,074,458 | $22.1M | 0.00% | +1,043,718+20.7% | Added |
| State Street Corp | 7,997,153 | $29.1M | 0.00% | +1,191,346+17.5% | Added |
| Vanguard Group Inc | 14,611,466 | $53.2M | 0.00% | +1,925,663+15.2% | Added |
| BlackRock, Inc. | 18,373,961 | $66.9M | 0.00% | +3,041,798+19.8% | Added |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −2,925,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −627,892−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −189,087−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −173,431−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −134,277−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −106,085−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −104,334−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −89,023−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −61,816−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −59,206−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −46,726−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −32,663−100.0% | Sold out |
| Unified Investment Management | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −10,510−100.0% | Sold out |
| Empirical Asset Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −5−100.0% | Sold out |